Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Assumes Skillsoft at Perform

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.
byBenzinga Newsdesk
July 27, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Oppenheimer analyst Ken Wong assumes Skillsoft (NYSE:SKIL) with a Perform rating.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Castle Biosciences Announces Publication Of Study Demonstrating DecisionDx-SCC Test Identifies High-Risk SCC Patients Benefiting Most From ART

By Benzinga Newsdesk
May 29, 4:32 PM
In the study, patients with DecisionDx-SCC Class 2B test results, predicted to have the highest risk of metastasis by the test, who were treated with adjuvant radiation therapy (ART) had 50% higher metastasis-free survival (MFS) rates, on average, and slowed disease progression compared to Class 2B patients who did not receive ART

CSTL